Shanghai Rongtai Health Technology Corporation Limited reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 564.8 million compared to CNY 520.32 million a year ago. Revenue was CNY 564.8 million compared to CNY 520.32 million a year ago. Net income was CNY 58.33 million compared to CNY 68.63 million a year ago. Basic earnings per share from continuing operations was CNY 0.44 compared to CNY 0.5 a year ago. Diluted earnings per share from continuing operations was CNY 0.42 compared to CNY 0.48 a year ago.